FDA Inspection 1020941 — Nanjing White Whale Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanjing White Whale Pharmaceutical Co., Ltd. on July 21, 2017 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 21, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Nanjing (China)